Ferozsons Laboratories Limited (PSX:FEROZ)
Pakistan
· Delayed Price · Currency is PKR 333.29
-5.30 (-1.57%)
At close: Mar 6, 2026
Ferozsons Laboratories Revenue
Ferozsons Laboratories had revenue of 6.68B PKR in the quarter ending December 31, 2025, with 41.25% growth. This brings the company's revenue in the last twelve months to 22.22B, up 32.13% year-over-year. In the fiscal year ending June 30, 2025, Ferozsons Laboratories had annual revenue of 18.86B with 18.94% growth.
Revenue (ttm)
22.22B
Revenue Growth
+32.13%
P/S Ratio
0.65
Revenue / Employee
14.28M
Employees
1,556
Market Cap
14.49B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 18.86B | 3.00B | 18.94% |
| Jun 30, 2024 | 15.85B | 4.40B | 38.38% |
| Jun 30, 2023 | 11.46B | 2.13B | 22.80% |
| Jun 30, 2022 | 9.33B | 450.80M | 5.08% |
| Jun 30, 2021 | 8.88B | 2.67B | 42.93% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Citi Pharma | 14.10B |
| Macter International | 11.58B |
| Highnoon Laboratories | 26.61B |
| The Searle Company | 33.26B |
| Otsuka Pakistan | 4.26B |
| AGP Limited | 27.73B |
| Abbott Laboratories (Pakistan) | 74.84B |
| GlaxoSmithKline Pakistan | 62.07B |